ScienceFirst/ Share price a very distant second Do not discuss share price!
Bencro, you seem to have a remarkably unlimited supply of information at your fingertips. Well beyond the scope of any other poster?
Why don’t you run a valuation model on Theralase. You know future revenue projections, discounted cash flows, that kind of thing.
Right, share price is not to be discussed. I know that, I know your posting history.